Activity and circulating plasma levels of FVIII protein are used to evaluate the severity of hemophilia A, which can be classified as severe, moderate, and mild, corresponding to FVIII protein levels of ≤1, 2–5, and 5–30%, respectively (Srivastava et al., 2013). This evidence concerns the gene F8 and hemophilia A.